Outspoken Oncology

Chadi Nabhan, MD, MBA, FACP, makes his rounds at the Summit on National and Global Cancer Health Disparities, interviewing guests such as Clifford Hudis, Otis Brawley, Edith Mitchell, and Ken Anderson.

Chadi Nabhan, MD, MBA, FACP, and Anirban Maitra, MD, director of pancreatic cancer research, The University of Texas MD Anderson Cancer Center, break down important touch points of screening in pancreatic cancer. They also discuss future research topics in adjuvant and metastatic setting and funding opportunities for junior investigators.

Chadi Nabhan, MD, MBA, FACP, and Anirban Maitra, MD, director of pancreatic cancer research, The University of Texas MD Anderson Cancer Center, break down important touch points of screening in pancreatic cancer. They also discuss future research topics in adjuvant and metastatic setting and funding opportunities for junior investigators.

Chadi Nabhan, MD, MBA, FACP, and Elaine Schattner, MD, MA, a breast cancer survivor, patient advocate, and former oncologist, breaks down the role of patient advocates in the ever-changing oncology treatment landscape. It is the advocates’ responsibility to educate patients about their treatment options through bias-free therapy information, she argues.

Chadi Nabhan, MD, MBA, FACP, and Elaine Schattner, MD, MA, a breast cancer survivor, patient advocate, and former oncologist, breaks down the role of patient advocates in the ever-changing oncology treatment landscape. It is the advocates’ responsibility to educate patients about their treatment options through bias-free therapy information, she argues.

Chadi Nabhan, MD, MBA, FACP, and Laurie Gordon, MD, dig into the extent of the clinician and health care provider burnout "crisis" in America. Localizing burnout in the individual is controversial because burnout is more of a system failure, Dr Gordon argues.

Chadi Nabhan, MD, MBA, FACP, and Laurie Gordon, MD, dig into the extent of the clinician and health care provider burnout "crisis" in America. Localizing burnout in the individual is controversial because burnout is more of a system failure, Dr Gordon argues.

Chadi Nabhan, MD, MBA, FACP, and Mark Wolfinger, a leukemia survivor, discuss some of the issues and concerns of navigating the cancer treatment landscape as a patient in today's health care system.

Chadi Nabhan, MD, MBA, FACP, and Mark Wolfinger, a leukemia survivor, discuss some of the issues and concerns of navigating the cancer treatment landscape as a patient in today's health care system.

Chadi Nabhan, MD, MBA, FACP, and Jack West, MD, discuss next-generation sequencing (NGS) and its controversies in oncology care. While some clinicians advocate NGS for all patients and all tumors, others, like Dr West, may contest this approach.